Selective immunoglobulin A (IgA) deficiency is a primary immunodeficiency disorder characterized by a significant reduction in serum and body secretion levels of immunoglobulin A. IgA plays a key role in the immune defense of mucous membranes and is the main antibody present in salivary secretions, tears, milk, and the intestinal mucosa. Patients with selective IgA deficiency are frequently susceptible to respiratory and gastrointestinal infections and may also have autoimmune diseases and allergies. The disease may present with a variety of clinical symptoms, but many people with this condition are bothered by recurring infections. Because of its subtle clinical presentation, IgA deficiency may remain undetected for a long time in many patients, making it difficult to diagnose and treat.
History of the disease and interesting historical facts
Selective IgA deficiency was first described in the 1960s, when researchers began to study primary immunodeficiencies. In the following decades, mechanisms explaining the causes of this condition were established. Interestingly, the first case of selective IgA deficiency was registered in a patient with a long history of allergic reactions and infectious diseases. Since then, many studies have been conducted to study the genetic, etiological and clinical aspects of this disease. Based on observations of patients with IgA deficiency, it has been found that the presence of this condition can be associated with other immunodeficiencies, as well as with syndromes characterized by insufficient antibody production.
Epidemiology
The epidemiology of selective IgA deficiency shows that it is the most common primary immunodeficiency worldwide. Estimates of incidence range from 1:300 to 1:500 individuals, but this number may be underestimated because many patients do not seek medical attention. Studies suggest that selective IgA deficiency is more common in men than in women, although the exact reasons for this sex predisposition remain unclear. The prevalence of IgA deficiency varies by geographic location, with incidence higher in northern Europe and parts of the Americas than in Asia and Africa. Importantly, there is an increased incidence of the condition among close relatives of patients with the deficiency, suggesting a possible hereditary predisposition.
Genetic predisposition to this disease
Genetic predisposition to selective IgA deficiency is largely determined by mutations in genes responsible for antibody production. Studies show that genes involved include genes encoding proteins responsible for normal B-lymphocyte and plasma cell activity. In particular, IgA deficiency is known to be associated with a heterozygous arrangement on chromosome 6 (HLA genes). It has been established that gene variants such as AIRE and IL-4 may influence the development of this condition. Patients with IgA deficiency also show changes in the expression of genes responsible for the production of other classes of immunoglobulins. This suggests that genetic factors play an important role in the pathogenesis of the disease, and further research in this area may lead to a better understanding of its mechanism.
Risk factors for the development of this disease
It is assumed that the occurrence of selective IgA deficiency may be caused by a combination of genetic and exogenous factors. The main risk factors include:
- Heredity - having a family history of the disease significantly increases the likelihood of developing IgA deficiency.
- Autoimmune diseases - the presence of other immune disorders may serve as a predictor for the development of IgA deficiency.
- Environmental factors - exposure to certain chemicals or infectious agents early in life may increase the risk.
- Gender of the patient - as mentioned, selective IgA deficiency is more common in men.
- Ethnic and racial factors - prevalence may vary among different populations and ethnic groups.
Despite the presence of these factors, the exact mechanisms of disease development still require further study, which opens up opportunities for new research in the field of treatment and prevention.
Diagnosis of this disease
The diagnosis of selective IgA deficiency is based on clinical findings, laboratory tests, and exclusion of other conditions. The main symptoms include:
- Frequent upper and lower respiratory tract infections.
- Gastrointestinal infections, including diarrhea and gastritis.
- Allergic reactions and autoimmune diseases.
- Symptoms of asthma and other bronchial diseases.
Laboratory tests include serum IgA levels and immunoassays to evaluate other classes of immunoglobulins. Radiologic studies may be indicated in the presence of multiple infections to rule out more complex conditions. A differential diagnosis should be made to exclude other primary and secondary immunodeficiencies, such as agammaglobulinemia or band syndrome.
Treatment
Treatment of selective IgA deficiency involves a comprehensive approach based on clinical manifestations. The main goal of treatment is to improve the patient's quality of life and reduce the incidence of infectious diseases. General treatment may include:
- Immunotherapy is the use of vaccines to stimulate the immune system's response.
- Supportive therapy is the administration of antibacterial agents to prevent infections.
- Symptomatic treatment is the use of medications to control symptoms such as allergies and inflammation.
Pharmacological treatment may include the use of corticosteroids if autoimmune phenomena occur. Surgery is rarely required, but may be performed if complications are severe, such as abscesses or other infections. Other treatments may include physical therapy and lifestyle changes to strengthen immune function.
List of medications used to treat this disease
Some of the medications most commonly used to treat patients with selective IgA deficiency include:
- Antibiotics for the prevention and treatment of infectious complications.
- Corticosteroids for the management of autoimmune manifestations.
- Antihistamines to control allergic reactions.
- Immunostimulants such as interferons to enhance the immune response.
Since IgA deficiency may manifest itself differently in different patients, the choice of medication should always be individualized and based on the clinical picture.
Disease monitoring
Monitoring of patients with selective IgA deficiency includes regular observation of their condition, assessment of the frequency of infectious episodes and monitoring of autoimmune conditions. Control steps may include:
- Regular laboratory determination of IgA and other immunoglobulin levels.
- Monitoring clinical symptoms and diseases.
- Screening for concomitant diseases, including allergies and autoimmune diseases.
The prognosis for most patients with selective IgA deficiency is generally good, but the likelihood and severity of infections remain major concerns. Complications may include severe infections and the development of secondary immunodeficiencies.
Age-related features of the disease
The course of selective IgA deficiency can vary considerably depending on the age of the patient. In children, the condition may be more pronounced because they are more susceptible to infections. During adolescence, the risk of frequent infections remains high, but spontaneous improvement may sometimes occur. In adults, patients with this deficiency may be better able to adapt and develop ways to manage symptoms, but may also be at risk of developing autoimmune diseases. In older people with pre-existing conditions, IgA levels may further decline, requiring careful monitoring.
Questions and Answers
- What is selective IgA deficiency? It is a primary immunodeficiency condition characterized by decreased levels of immunoglobulin A, leading to an increased risk of infections.
- How is selective IgA deficiency diagnosed? Diagnosis is based on clinical findings, laboratory determination of IgA levels, and exclusion of other possible conditions.
- What are the symptoms of selective IgA deficiency? The main symptoms include frequent respiratory infections, gastrointestinal disorders and allergic reactions.
- Can selective IgA deficiency be cured? There is no complete cure, but symptoms can be controlled and quality of life improved with immunotherapy and drug treatment.
- What risk factors may contribute to the development of IgA deficiency? Risk factors include heredity, the presence of other immune diseases, and certain environmental conditions.
